Estrella Immunopharma (NASDAQ:ESLA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Estrella Immunopharma (ESLA) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Estrella Immunopharma Stock (NASDAQ: ESLA) stock price, news, charts, stock research, profile.

Open	$1.06
Close	$1.16
Volume / Avg.	8.32K / 138.03K
Day Range	$1.06 - $1.19
52 Wk Range	0.63 - 3.23
Market Cap	$41.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	0.37%
Days to Cover	1.49

Recent News

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.06
Close	$1.16
Volume / Avg.	8.32K / 138.03K
Day Range	$1.06 - $1.19
52 Wk Range	0.63 - 3.23
Market Cap	$41.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	0.37%
Days to Cover	1.49

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Estrella Immunopharma (ESLA) stock?

You can purchase shares of Estrella Immunopharma (NASDAQ:ESLA) through any online brokerage.

View our list of the best stock brokerages

Who are Estrella Immunopharma (ESLA) competitors?

Other companies in Estrella Immunopharma’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX), Barinthus Biotherapeutics (NASDAQ:BRNS) and FibroGen (NASDAQ:FGEN).

What is the forecast, or price target, for Estrella Immunopharma (ESLA) stock?

There is no analysis for Estrella Immunopharma to provide a consensus price target.

What is the current price for Estrella Immunopharma (ESLA)?

The stock price for Estrella Immunopharma (NASDAQ: ESLA) is $1.16 last updated December 20, 2024 at 4:00 PM EST.

Does Estrella Immunopharma (ESLA) pay a dividend?

There are no upcoming dividends for Estrella Immunopharma.

When is Estrella Immunopharma (NASDAQ:ESLA) reporting earnings?

Estrella Immunopharma’s Q2 earnings are confirmed for Wednesday, February 12, 2025.

Is Estrella Immunopharma (ESLA) going to split?

There is no upcoming split for Estrella Immunopharma.

What sector and industry does Estrella Immunopharma (ESLA) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Estrella Immunopharma

Estrella Immunopharma (ESLA) Forecast